TNF and plasma cell myeloma: We conclude that, coupled with our prior work showing that ex vivo virotherapy with unarmed MYXV can be an effective therapeutic strategy against multiple myeloma in the BM and spleen,31 this systemic delivery strategy with TNF-armed MYXV can effectively treat metastatic disease in the lung.